Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Hyperphagia 5Stomach Neoplasms 2Pancreatic Neoplasms 2Malnutrition 2Nutritional Support 1Glucocorticoid Receptor Deficiency 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Digestive System Neoplasms 1

Interventions

Oxaliplatin 295Capecitabine 209Fluorouracil 183Cisplatin 172Docetaxel 140S 1 (combination) 135Paclitaxel 128Leucovorin 117Irinotecan 110pembrolizumab 104Trastuzumab 75Nivolumab 59apatinib 57Drug Therapy 52sintilimab 46Surgical Procedures, Operative 45Ramucirumab 40Radiotherapy 40Bevacizumab 37Hyperthermic Intraperitoneal Chemotherapy 34Epirubicin 32titanium silicide 31tislelizumab 31Carboplatin 31Gastrectomy 28Cyclophosphamide 27XELOX 25Tegafur 24Folfox protocol 23Albumin-Bound Paclitaxel 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Stomach Neoplasms × Parenteral Nutrition × Gastrointestinal × Clear all
NCT07604857 2026-05-22

BRIDGE-GC

The Catholic University of Korea

Phase NA Completed
55 enrolled
Gastrointestinal

Hyperphagia, Stomach Neoplasms

NCT00558155 2007-11-14

The Impact of Immunostimulating Nutrition on the Outcome of Surgery

Jagiellonian University

Phase 4 Completed
214 enrolled
Gastrointestinal

Hyperphagia, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡